Patients and Visitors Learn About Clinical Trials Find a Clinical Trial Pulmonary and Critical Care Medicine 1882806 ALIS Clinical Trial

ALIS in Participants with Nontuberculous Mycobacterial Lung Infection caused by Mycobacterium Avium Complex

A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC).

This research study is led by: Dr. O'Neil Green

Participation Details:

April 21, 2023
January 30, 2023
1882806
Pulmonary/ Critical Care, Infection
Dr. O'Neil Green
Baystate Medical Center
The purpose of the clinical trial is to assess a study drug as a potential treatment option for patients newly diagnosed with a MAC lung infection.
Inclusion
  • Current diagnosis of MAC lung infection. MAC or mixed infection with MAC as the dominant species is allowed, with MAC as the intended organism for treatment.
Exclusion
  • Diagnosis of cystic fibrosis (CF)
  • History of more than 3 MAC lung infections.
  • Received any mycobacterial antibiotic treatment for current MAC lung infection.
17.5 months
Active
Outpatient
3b
Dr. O'Neil Green
413-794-7330